Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes
Open Access
- 29 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e70064
Abstract
The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-factorial and complex. Identifying patterns of treatment interruption that predict poor outcomes can be used to target program activities aiming to improve treatment adherence. To characterize patterns of treatment interruption among MDR TB patients and determine the association between patterns and treatment outcomes. Retrospective analysis of MDR TB patients. A treatment interruption was defined as any time that a patient missed a prescribed dose of treatment for at least 1 day but for a period of less than 2 consecutive months. Patients were characterized by the number, length and variability of interruptions, variability of time between interruptions, and percent of missed doses. Final treatment outcome was dichotomized as a successful (cured or completed) or poor outcome (defaulted, failed, or died). Risk ratios were calculated to determine the association between characteristics of treatment interruption and treatment outcomes. All analyses were conducted in 6 month treatment intervals. Only 7.0% of 583 patients completed treatment without interruption. Of the remaining 542 patients, the median time to the first interruption was 2 ½ months (70 days). In multivariate analysis, patients who had longer interruptions with sporadic variability during the 6–12 month or the 12–18 month treatment period had a significantly increased risk for poor outcomes compared to patients who had short, regular interruptions (RRadj 4.37, 95% CI 1.2–15.8; = 0.03 and RRadj 3.38, 95% CI 1.6–7.1; p = 0.001, respectively). In addition, missing 10% or more of the prescribed doses during any 6 month period in the initial 18 months of therapy significantly increased the risk for poor outcomes (RRadj range 1.55–2.35; p-value range 0.01–0.005). Patients that miss more consecutive days of treatment with sporadic interruption patterns or a greater proportion of treatment are at an increased risk for poor treatment outcomes.Keywords
This publication has 13 references indexed in Scilit:
- Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2012
- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisBMC Infectious Diseases, 2011
- Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera), Nairobi, Kenya: what are the rates and determinants?Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011
- Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control studyBMC Public Health, 2010
- Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative studyBMC Health Services Research, 2009
- Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of RussiaInternational Journal of Infectious Diseases, 2009
- Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative studyBMC Public Health, 2008
- Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative ResearchPLOS Medicine, 2007
- Factors Associated With Tuberculosis Treatment Interruption in New York CityJournal of Public Health Management & Practice, 2005
- Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.2005